[Composition of the Belgian influenza vaccines for the 2015-2016 season].
Identifieur interne : 000024 ( Main/Exploration ); précédent : 000023; suivant : 000025[Composition of the Belgian influenza vaccines for the 2015-2016 season].
Auteurs : M. Van SteenkisteSource :
- Journal de pharmacie de Belgique [ 0047-2166 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Grippe humaine, Vaccins antigrippaux.
- Belgique, Grippe humaine, Humains, Saisons, Vaccination, Vaccins antigrippaux.
- Wicri :
- geographic : Belgique.
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Influenza Vaccines.
- chemical , immunology : Influenza Vaccines.
- geographic : Belgium.
- immunology : Influenza, Human.
- prevention & control : Influenza, Human.
- Humans, Seasons, Vaccination.
Abstract
This article gives an update on how the composition of the influenza virus vaccine is determined, how the infection spreads, and what the consequences are of the disease. Next flu season for the first time a quadrivalent and intranasal vaccine will be available on the Belgian market. What is the difference with what we know until now? Is there an added value? How about the contraindications? Furthermore we elaborate on the composition of the influenza vaccine on the Belgian market for the season 2015-2016 and we give a reminder of the patient groups with a high risk for complications. As pharmacists we should motivate these patients to get themselves vaccinated. Finally, we discuss the reimbursement conditions of the National Institute for Health and Disability Insurance INIHDII.
PubMed: 26513832
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Composition of the Belgian influenza vaccines for the 2015-2016 season].</title><author><name sortKey="Van Steenkiste, M" sort="Van Steenkiste, M" uniqKey="Van Steenkiste M" first="M" last="Van Steenkiste">M. Van Steenkiste</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26513832</idno><idno type="pmid">26513832</idno><idno type="wicri:Area/Main/Corpus">000027</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000027</idno><idno type="wicri:Area/Main/Curation">000027</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000027</idno><idno type="wicri:Area/Main/Exploration">000027</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Composition of the Belgian influenza vaccines for the 2015-2016 season].</title><author><name sortKey="Van Steenkiste, M" sort="Van Steenkiste, M" uniqKey="Van Steenkiste M" first="M" last="Van Steenkiste">M. Van Steenkiste</name></author></analytic><series><title level="j">Journal de pharmacie de Belgique</title><idno type="ISSN">0047-2166</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Belgium</term><term>Humans</term><term>Influenza Vaccines (chemistry)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Seasons</term><term>Vaccination</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Belgique</term><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Humains</term><term>Saisons</term><term>Vaccination</term><term>Vaccins antigrippaux ()</term><term>Vaccins antigrippaux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Belgium</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Seasons</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Belgique</term><term>Grippe humaine</term><term>Humains</term><term>Saisons</term><term>Vaccination</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Belgique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This article gives an update on how the composition of the influenza virus vaccine is determined, how the infection spreads, and what the consequences are of the disease. Next flu season for the first time a quadrivalent and intranasal vaccine will be available on the Belgian market. What is the difference with what we know until now? Is there an added value? How about the contraindications? Furthermore we elaborate on the composition of the influenza vaccine on the Belgian market for the season 2015-2016 and we give a reminder of the patient groups with a high risk for complications. As pharmacists we should motivate these patients to get themselves vaccinated. Finally, we discuss the reimbursement conditions of the National Institute for Health and Disability Insurance INIHDII.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26513832</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0047-2166</ISSN><JournalIssue CitedMedium="Print"><Issue>3</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal de pharmacie de Belgique</Title><ISOAbbreviation>J Pharm Belg</ISOAbbreviation></Journal><ArticleTitle>[Composition of the Belgian influenza vaccines for the 2015-2016 season].</ArticleTitle><Pagination><MedlinePgn>14-23</MedlinePgn></Pagination><Abstract><AbstractText>This article gives an update on how the composition of the influenza virus vaccine is determined, how the infection spreads, and what the consequences are of the disease. Next flu season for the first time a quadrivalent and intranasal vaccine will be available on the Belgian market. What is the difference with what we know until now? Is there an added value? How about the contraindications? Furthermore we elaborate on the composition of the influenza vaccine on the Belgian market for the season 2015-2016 and we give a reminder of the patient groups with a high risk for complications. As pharmacists we should motivate these patients to get themselves vaccinated. Finally, we discuss the reimbursement conditions of the National Institute for Health and Disability Insurance INIHDII.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Steenkiste</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Composition des vaccins contre l'influenza commercialisés en Belgique pour la saison 2015-2016.</VernacularTitle></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>J Pharm Belg</MedlineTA><NlmUniqueID>0375351</NlmUniqueID><ISSNLinking>0047-2166</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26513832</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Van Steenkiste, M" sort="Van Steenkiste, M" uniqKey="Van Steenkiste M" first="M" last="Van Steenkiste">M. Van Steenkiste</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeBelgiqueV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000024 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000024 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeBelgiqueV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26513832
|texte= [Composition of the Belgian influenza vaccines for the 2015-2016 season].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26513832" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeBelgiqueV4
| This area was generated with Dilib version V0.6.35. |  |